All One Health Content – Page 140
-
NewsMainstay malaria drug may be beginning to fail in the Horn of Africa
In eastern Africa, malaria parasites have developed resistance to artemisinins, the backbone of current treatment regimens, a development that could dramatically worsen malaria’s impact if partner drugs fail in the future.
-
NewsInfamous ‘eagle killer’ cyanobacterium produces not one, but two toxins
Two years ago, researchers established that a toxin from the cyanobacterium Aetokthonos hydrillicola is the cause of a mysterious disease among bald eagles in the USA - now they have described an elusive second toxin.
-
NewsResearchers combat Zika-associated foetal abnormalities using microRNA
Researchers have studied how the Zika virus persists in the placenta for long periods of time and how to mitigate it.
-
NewsNew coronavirus-capturing material could transform the face mask
Researchers have developed a new material that captures coronavirus particles and could transform the efficiency of face masks.
-
NewsHERV-W virus acting as neuropathogen successfully confirmed
Scientists have described a direct functional connection between the release of an endogenous retrovirus and the worsening of neurodegenerative processes in multiple sclerosis.
-
NewsNew test for sepsis could save lives in emergency departments
Interdisciplinary research has found that a new blood test for sepsis could save lives and money.
-
NewsSRI spins off AI-powered drug discovery platform Synfini, Inc
SRI International has announced it is spinning off Synfini, a biosciences platform that accelerates the process by which pharmaceutical and other companies can design, synthesize, and bring to market molecules for drug development.
-
CareersResearchers find contaminated water in fast-food soda fountains
Scientists found microbial contamination in common sources of drinking water in the Eastern Coachella Valley, including soda fountains at fast-food restaurants.
-
NewsContagious omicron strain replicates early in infection
New research used engineered mice to compare SARS-COV-2 omicron subvariants and found one of them – BA.5 – was more virulent likely due to its ability to rapidly replicate early during infection.
-
NewsValneva announces new IXIARO® supply contract with the US government
Specialty vaccine company Valneva SE has announced the signing of a new $32 million contract with the United States Department of Defense for the supply of its Japanese encephalitis vaccine, IXIARO®.
-
NewsAntibiotics can help some bacteria survive for longer
Scientists have found a surprising effect of some antibiotics on certain bacteria – that the drugs can sometimes benefit bacteria, helping them live longer.
-
NewsResearchers pioneer safe chemotherapy methods for treating bacterial infections
Antibiotic resistant bacteria are a threat to human lives, and yet the development of new drugs to treat bacterial infections is slow. A group of proven drugs used in cancer treatment for decades could possibly be the solution. A new class of antibiotics is now being developed by researchers at ...
-
OpinionMuch ado about microbes
A group of leading scientists has recently reviewed the benefits and risks of Gain of Function research and issued new consensus recommendations - Simon Wain-Hobson examines the report exclusively for The Microbiologist.
-
NewsNew vaccine technology could protect from future viruses and variants
Studies of a ‘future-proof’ vaccine candidate have shown that just one antigen can be modified to provide a broadly protective immune response in animals.
-
NewsAssays for rapid and visual detection of monkey B virus
Two recombinase polymerase amplification (RPA) assays have been developed for Monkey B virus that target two conserved genes combined with a one-off, closed visualization strip device
-
NewsNew research reveals gut microbiota link to colitis - and therapetic strategies
Researchers have revealed a new and critical role of Axin1 in regulating intestinal epithelial development and microbial homeostasis.
-
-
NewsNanoparticle vaccine candidate shows promise against emerging tick-borne virus
Researchers have used nanoparticles to develop a potential vaccine candidate against Dabie Bandavirus, formerly known as Severe Fever with Thrombocytopenia Syndrome Virus (SFTSV), a tick-borne virus that has no prevention, treatment or cure.
-
NewsHops compound reduces abundance of gut microbe associated with metabolic syndrome
Researchers have shown in a mouse model and lab cultures that a compound derived from hops reduces the abundance of a gut bacterium associated with metabolic syndrome.
-
NewsDiscovery in mosquitoes could lead to new strategy against dengue fever
Researchers have discovered that a protein in the mosquito Aedes aegypti , Argonaute 2, has a key role - via several biological mechanisms - in keeping mosquitoes healthy and active despite the presence of viral infections like dengue and Zika.